Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer

Extracellular Tropomyosin: A Novel Common Pathway Target for Anti- Angiogenic Therapy

Volume:4   Issue: 7
Pp: 543-553
Fernando Donate, Keith McCrae, David E. Shaw and Andrew P. Mazar
DOI: 10.2174/1568009043332781

Angiotensin-I Converting Enzyme Inhibitors as Potential Anti-Angiogenic Agents for Cancer Therapy

Volume:4   Issue: 7
Pp: 555-567
Hitoshi Yoshiji, Shigeki Kuriyama, Ryuichi Noguchi and Hiroshi Fukui
DOI: 10.2174/1568009043332790

Targeting Apoptosis Pathways in Cancer Therapy

Volume:4   Issue: 7
Pp: 569-576
Simone Fulda and Klaus-Michael Debatin
DOI: 10.2174/1568009043332763

Chemotherapeutic Agents That Induce Mitochondrial Apoptosis

Volume:4   Issue: 7
Pp: 577-590
Tadashi Asakura and Kiyoshi Ohkawa
DOI: 10.2174/1568009043332772

Alphaviruses and their Derived Vectors as Anti-Tumor Agents

Volume:4   Issue: 7
Pp: 597-607
Gregory J. Atkins, James W. P. Smyth, Marina N. Fleeton, Sareen E. Galbraith and Brian J. Sheahan
DOI: 10.2174/1568009043332754